Additional funding of $20 million accelerates commercialization of Trailhead’s iPSC-derived human cell and media products. BEACHWOOD, Ohio and CAMBRIDGE, Mass. — Trailhead Biosystems Inc. (www.trailbio.com), a biotechnology company advancing human cell innovation, has added $20 million in new funding, expanding the financing announced in May 2025 to $40 million. The funding extension was led by […]
Appointment strengthens leadership team as iXCells focuses on expanding its portfolio of custom-tailored iPSC products and delivery of enhanced preclinical services San Diego, CA: iXCells Biotechnologies (“iXCells”), a leading provider of human cell-based solutions and custom iPSC services, today announced the appointment of Steve Smith as CEO. Previously CCO, Steve will lead the Company to advance […]
Genialis Expressions empowers drug development teams to make confident decisions by unifying workflows and standardizing omics data for enterprise-grade clarity and comparability across studies BOSTON & LAUSANNE, Switzerland — Genialis, the RNA biomarker company, today announced that Swiss-based biopharmaceutical company Debiopharm has deployed the Genialis™ Expressions software platform within its cloud infrastructure to support biomarker discovery and […]
London – M&G Investments (M&G) today announces that it is leading a US$50 million Series C funding round for bit.bio, the Cambridge-based biotech company pioneering next-generation human cell programming technology. The investment of patient capital into a fast-growing private UK company, spun out from the University of Cambridge, marks a major vote of confidence in […]
Abbelight Announces Successful Series B Investment led by AVANT BIO to accelerate imaging innovation and scale adoption across a broader customer base. Paris, France – January 8, 2026 – Abbelight, a global leader and a pioneer in super-resolution microscopy end-to-end solutions, today announced a successful Series B financing round led by AVANT BIO, a growth […]
Waltham, Mass. – Vizgen, Inc., a leader in spatial multi-omics, today announced the closing of a $48 million financing. The financing was led by ARCH Venture Partners and co-led by M Ventures and Northpond Ventures with participation from the company’s existing investors. Proceeds from the round will be used to execute on Vizgen’s innovation roadmap, expand […]
New partnership combines Factorial’s in-cell library preparation chemistry with Honeycomb’s HIVE™ platform to enable scalable single-cell WGS workflow with processing capacity up to 1 million cells per day. SAN CARLOS, Calif., and WALTHAM, Mass. — Factorial Biotechnologies, a leader in next-generation single-cell sequencing solutions, and Honeycomb Biotechnologies, a pioneer in instrument-free single-cell analysis, today announced […]
MONMOUTH JUNCTION, N.J. and TOKYO — TheWell Bioscience Inc., a biotechnology company pioneering next-generation animal-free biofunctional hydrogels, and PeptiGrowth Inc., a leader in innovative synthetic peptide growth factors, today announced that the two companies have entered into a Marketing Collaboration Agreement to jointly promote cutting-edge solutions for stem cell culture, organoid development, and cell therapy manufacturing. TheWell Bioscience manufactures VitroGel®, an […]
Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling Brisbane, CA – CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced […]
Singapore – Singleron Biotechnologies, a global leader in single cell multi-omics solutions, today announced a strategic partnership with DKSH, a leading distributor of advanced life science products in Australia and New Zealand. With this partnership, DKSH will become the exclusive distributor of Singleron’s innovative single cell multi-omics solutions in Australia and New Zealand. DKSH will provide Singleron’s comprehensive […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
